{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T11:47:22Z","timestamp":1747223242679,"version":"3.40.5"},"reference-count":30,"publisher":"Pensoft Publishers","issue":"6","license":[{"start":{"date-parts":[[2023,12,31]],"date-time":"2023-12-31T00:00:00Z","timestamp":1703980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["FM"],"abstract":"<jats:p><jats:bold>Introduction<\/jats:bold>: Carotid stenting may produce significant bradycardia and\/or hypotension. This may have negative short- and long-term effects for the elderly high-risk patients. Their cerebral hemodynamics is with exhausted adaptive capacity because of the multiple cardiovascular risk factors, advanced age, and significant stenosis.<\/jats:p>\n          <jats:p><jats:bold>Aim<\/jats:bold>: This was a retrospective study aimed at finding whether periprocedural hypoperfusion or hypotension at the time of carotid stenting had any significance for the acute neurological outcome and mid-term general mortality in advanced-age patients who were at high risk for surgical endarterectomy.<\/jats:p>\n          <jats:p><jats:bold>Materials and methods<\/jats:bold>: We studied 138 consecutive patients with significant carotid stenosis from January 2015 to July 2019. The mean (SD) age was 67.41 (10.70) years. The mean follow-up period was 31 months (922 days). The patients were hemodynamically monitored periprocedurally according to a local protocol. Vasopressors were added if a prolonged hypotension was measured. Statistical data were analyzed using SPSS IBM v. 19 (<jats:italic>p<\/jats:italic>=0.05, CI 95%).<\/jats:p>\n          <jats:p><jats:bold>Results<\/jats:bold>: The male patients were 94 (68%). The number of patients with hypotension periprocedurally or in the first 6 hours post-procedure was 55 (42%). The mean blood pressures were 135\/83 mmHg before, 116\/76 mmHg during, and 121\/73 mmHg after the procedure. Kaplan-Maier analysis showed no significant differences in the mid-term general mortality rate between patients with and patients without transitory hypotension. There wasn\u2019t any difference in the postprocedural neurological outcome either.<\/jats:p>\n          <jats:p><jats:bold>Conclusions<\/jats:bold>: The presence of hypotension during carotid stenting was not linked to a negative neurological outcome. It also did not increase mid-term all-cause mortality in elderly patients (mean age, 67 years). The finding could be attributed to the relatively brief period of hypotension, the prompt administration of vasopressors, or the prevention of brain edema and hyper-reperfusion during carotid stenting in terms of elevated blood pressure; however, this remains to be determined.<\/jats:p>","DOI":"10.3897\/folmed.65.e100100","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T15:08:45Z","timestamp":1703862525000},"page":"902-908","source":"Crossref","is-referenced-by-count":1,"title":["The role of periprocedural hemodynamic variables during carotid stenting for the mid-term general mortality in advanced age patients"],"prefix":"10.3897","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8331-255X","authenticated-orcid":true,"given":"Teodora","family":"Yaneva-Sirakova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6097-7636","authenticated-orcid":true,"given":"Galina","family":"Zlatancheva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiril","family":"Karamfiloff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Latchezar","family":"Traykov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9989-0730","authenticated-orcid":true,"given":"Ivo","family":"Petrov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8249-2640","authenticated-orcid":true,"given":"Dobrin","family":"Vassilev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2258","published-online":{"date-parts":[[2023,12,31]]},"reference":[{"key":"100100_B1","doi-asserted-by":"crossref","unstructured":"1. Lavoie P, Rutledge J, Dawoud M, et al. Predictors and timing of hypotension and bradycardia after carotid artery stenting. Amer J Neuroradiol 2008; 29(10):1942\u20137.","DOI":"10.3174\/ajnr.A1258"},{"key":"100100_B2","unstructured":"2. Andani R, Khan YS. Anatomy. Head and Neck, Carotid Sinus. [Updated 2020 Feb 19]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554378"},{"key":"100100_B3","doi-asserted-by":"crossref","unstructured":"3. Aboyans V, Ricco J, Bartelinf M, et al. 2017 ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of the extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO), The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 2018; 39(9):763\u2013816.","DOI":"10.1093\/eurheartj\/ehx095"},{"key":"100100_B4","doi-asserted-by":"crossref","unstructured":"4. Zarrinkoob L, Wahlin A, Ambarki K, et al. Blood flow lateralization and collateral compensatory mechanisms in patients with carotid artery stenosis. Stroke 2019; 50:1081\u20138.","DOI":"10.1161\/STROKEAHA.119.024757"},{"key":"100100_B5","doi-asserted-by":"crossref","unstructured":"5. Lin P, Ahou W, Kougias P, et al. Factors associated with hypotension and bradycardia after carotid angioplasty and stenting. J Vasc Surg 2007; 46:846\u201354.","DOI":"10.1016\/j.jvs.2007.07.020"},{"key":"100100_B6","doi-asserted-by":"crossref","unstructured":"6. Nanto M, Goto Y, Yamamoto H, et al. Complications and predictors of hypotension requiring vasopressor after carotid artery stenting. Neurol Med Chir (Tokyo) 2017; 57(3):115\u201321.","DOI":"10.2176\/nmc.oa.2016-0155"},{"key":"100100_B7","doi-asserted-by":"crossref","unstructured":"7. Mylonas S, Moulakakis K, Antonopoulos C, et al. Carotid artery stenting-induced hemodynamic instability. J Endovasc Ther 2013; 20(1):48\u201360.","DOI":"10.1583\/12-4015.1"},{"key":"100100_B8","doi-asserted-by":"crossref","unstructured":"8. Wu T, Ham S, Katz S. Predictors and consequences of hemodynamic instability after carotid artery stenting. Ann Vasc Surg 2015; 29(6):1281\u20135.","DOI":"10.1016\/j.avsg.2015.03.035"},{"key":"100100_B9","doi-asserted-by":"crossref","unstructured":"9. Bussiere M, Lownie S, Lee D, et al. Hemodynamic instability during carotid artery stenting: the relative contribution of stent deployment versus balloon dilation. J Neurosurg 2009; 110(5):905\u201312.","DOI":"10.3171\/2008.9.JNS08509"},{"key":"100100_B10","doi-asserted-by":"crossref","unstructured":"10. Nonaka T, Oka S, Miyata S, et al. Risk factors of postprocedural hypotension following carotid artery stenting. Interv Neuroradiol 2006; 12:205\u201310.","DOI":"10.1177\/15910199060120S137"},{"key":"100100_B11","doi-asserted-by":"crossref","unstructured":"11. Arhuidese I, Ottinger M, Shukla A, et al. Hemodynamic events during carotid stenting are associated with significant periprocedural stroke and adverse events. J Vasc Surg 2020; 71(6):1941\u201353.","DOI":"10.1016\/j.jvs.2019.05.056"},{"key":"100100_B12","doi-asserted-by":"crossref","unstructured":"12. Boulanger M, Touze E. Periprocedural risk of myocardial infarction after carotid endarterectomy and carotid angioplasty and stenting. Arch Cardiovasc Dis 2016; 109:159\u201362.","DOI":"10.1016\/j.acvd.2015.10.003"},{"key":"100100_B13","unstructured":"13. Tomsick T. TIMI, TIBI, TICI: I came, I saw, I got confused. Am J Neuroradiol 2007; 28(2):382\u20134."},{"key":"100100_B14","doi-asserted-by":"crossref","unstructured":"14. Bonati LH, Kakkos S, Berkefeld J, et al. European Stroke Organisation guideline on endarterectomy and stenting for carotid artery stenosis. Eur Stroke J 2021; 6(2):I-XLVII. Available from: https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/23969873211012121, retrieved on 06.07.2021","DOI":"10.1177\/23969873211012121"},{"key":"100100_B15","doi-asserted-by":"crossref","unstructured":"15. Liu Y, Qin H, Zhang B, et al. Efficacy of different types of self-expandable stents in carotid artery stenting for carotid bifurcation stenosis. J Huazhong Univ Sci Technolog Med Sci 2016; 36(1):95\u20138.","DOI":"10.1007\/s11596-016-1548-0"},{"key":"100100_B16","unstructured":"16. Castriota F, Liso A, Biamino G, et al. Technical evolution of carotid stents. Interv Cardiol Rev Available from: https:\/\/www.icrjournal.com\/articles\/technical-evolution-carotid-stents (Retrieved on 06.07.2021)."},{"key":"100100_B17","doi-asserted-by":"crossref","unstructured":"17. Tallarite T, Rabinstein A, Cloft H, et al. Are distal protection devices \u201cprotective\u201d during carotid angioplasty and stenting? Stroke 2011; 42:1962\u20136.","DOI":"10.1161\/STROKEAHA.110.607820"},{"key":"100100_B18","doi-asserted-by":"crossref","unstructured":"18. Ahn S, Prince E, Dubel G. Carotid artery stenting: review of technique and update of recent literature. Semin Intervent Radiol 2013; 30(3):288\u201396.","DOI":"10.1055\/s-0033-1353482"},{"key":"100100_B19","doi-asserted-by":"crossref","unstructured":"19. Ogata A, Sonobe M, Kato N, et al. Carotid artery stenting without post-stenting balloon dilatation. J Neurointerv Surg 2014; 6:517\u201320.","DOI":"10.1136\/neurintsurg-2013-010873"},{"key":"100100_B20","doi-asserted-by":"crossref","unstructured":"20. Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension 2020; 75(6):1334\u201357.","DOI":"10.1161\/HYPERTENSIONAHA.120.15026"},{"key":"100100_B21","doi-asserted-by":"crossref","unstructured":"21. McEniery C, Cockcroft J, Roman M, et al. Central blood pressure: current evidence and clinical importance. Eur Heart J 2014; 35(26):1719\u201325.","DOI":"10.1093\/eurheartj\/eht565"},{"key":"100100_B22","doi-asserted-by":"crossref","unstructured":"22. Mitchell G. Central pressure should not be used in clinical practice. Artery Res 2015; 9:8\u201313.","DOI":"10.1016\/j.artres.2014.11.002"},{"key":"100100_B23","doi-asserted-by":"crossref","unstructured":"23. De Boer I, Bangalore S, Benetos, et al. Diabetes and hypertension: a position statement by the American Diabetes Association. Diabetes Care 2017; 40(9):1273\u201384.","DOI":"10.2337\/dci17-0026"},{"key":"100100_B24","doi-asserted-by":"crossref","unstructured":"24. Goksal E, Niftaliyev E, Deniz C, et al. Prolonged hypotension after carotid artery stenting: incidence, predictors and consequences. Acta Neurochir (Wien) 2017; 159(11):2081\u20137.","DOI":"10.1007\/s00701-017-3295-9"},{"key":"100100_B25","doi-asserted-by":"crossref","unstructured":"25. Mylonas S, Moulakakis K, Antonopoulos C, et al. Carotid artery stenting-induced hemodynamic instability. J Endovasc Ther 2013; 20(1):48\u201360.","DOI":"10.1583\/12-4015.1"},{"key":"100100_B26","doi-asserted-by":"crossref","unstructured":"26. Chang A, Hung H, Hsieh F, et al. Beneficial effects of prolonged blood pressure control after carotid artery stenting. Clin Interv Aging 2017; 12:103\u20139.","DOI":"10.2147\/CIA.S122352"},{"key":"100100_B27","doi-asserted-by":"publisher","DOI":"10.1177\/152660280301000501"},{"key":"100100_B28","doi-asserted-by":"crossref","unstructured":"28. Arnett D, Blumenthal R, Albert M, et al. 2019 ACC\/AHA Guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidliens. Circulation 2019; 140;e596\u2013e646.","DOI":"10.1161\/CIR.0000000000000725"},{"key":"100100_B29","doi-asserted-by":"crossref","unstructured":"29. Pirpoli M, Hoes A, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2016; 37:2315\u201381.","DOI":"10.1093\/eurheartj\/ehw106"},{"key":"100100_B30"}],"container-title":["Folia Medica"],"original-title":[],"link":[{"URL":"https:\/\/foliamedica.bg\/article\/100100\/download\/pdf\/","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/foliamedica.bg\/article\/100100\/download\/xml\/","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/foliamedica.bg\/article_preview.php?id=100100&skip_redirect=1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T15:09:27Z","timestamp":1703862567000},"score":1,"resource":{"primary":{"URL":"https:\/\/foliamedica.bg\/article\/100100\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,31]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,12,31]]}},"URL":"https:\/\/doi.org\/10.3897\/folmed.65.e100100","relation":{},"ISSN":["1314-2143","0204-8043"],"issn-type":[{"type":"electronic","value":"1314-2143"},{"type":"print","value":"0204-8043"}],"subject":[],"published":{"date-parts":[[2023,12,31]]}}}